BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29730697)

  • 1. Risk-related
    Spadafora M; Pace L; Evangelista L; Mansi L; Del Prete F; Saladini G; Miletto P; Fanti S; Del Vecchio S; Guerra L; Pepe G; Peluso G; Nicolai E; Storto G; Ferdeghini M; Giordano A; Farsad M; Schillaci O; Gridelli C; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1908-1914. PubMed ID: 29730697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
    Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.
    Evangelista L; Cuocolo A; Pace L; Mansi L; Del Vecchio S; Miletto P; Sanfilippo S; Pellegrino S; Guerra L; Pepe G; Peluso G; Salvatore M; Galicchio R; Zuffante M; Annunziata S; Farsad M; Chiaravalloti A; Spadafora M
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1898-1907. PubMed ID: 29736699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian Tailored Assessment of Lung Indeterminate Accidental Nodule by Proposing a Segmental Pet/Computed Tomography (s-Pet/Ct): Rationale And Study Design of a Retrospective, Multicenter Trial.
    Evangelista L; Spadafora M; Pace L; Mansi L; Cuocolo A
    Curr Radiopharm; 2018; 11(1):46-49. PubMed ID: 28969583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
    Spadafora M; Evangelista L; Gridelli C; Cuocolo A
    Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
    Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is
    Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
    Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.
    Grgic A; Yüksel Y; Gröschel A; Schäfers HJ; Sybrecht GW; Kirsch CM; Hellwig D
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1087-94. PubMed ID: 20140611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
    Şahin E; Kara A; Elboğa U
    Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
    Li W; Pang H; Liu Q; Zhou J
    Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT.
    Park KS; Seon HJ; Yun JS; Yoo SW; Lee C; Kang SR; Kim J; Cho SG; Song HC; Bom HS; Min JJ; Kwon SY
    Medicine (Baltimore); 2022 Feb; 101(5):e28764. PubMed ID: 35119036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
    Herder GJ; Golding RP; Hoekstra OS; Comans EF; Teule GJ; Postmus PE; Smit EF
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1231-6. PubMed ID: 15175835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of ¹⁸F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis.
    Li Y; Su M; Li F; Kuang A; Tian R
    Ann Nucl Med; 2011 Dec; 25(10):804-11. PubMed ID: 21879296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
    Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.